Stay updated with breaking news from Score Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TD Asset Management Inc lowered its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 8.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 385,215 shares of the medical research company’s stock after selling 34,655 shares during […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 2,000 shares of Exact Sciences stock in a transaction that occurred on Thursday, December 14th. The shares were sold at an average price of $70.00, for a total transaction of $140,000.00. Following the sale, the executive vice president now owns 71,423 shares of […]
Many Bright Ideas Technologies (OTCMKTS:MBGNF – Get Free Report) and Exact Sciences (NASDAQ:EXAS – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations. Insider & Institutional Ownership 89.1% of […]
Guggenheim started coverage on shares of Exact Sciences (NASDAQ:EXAS – Free Report) in a report released on Thursday morning, Marketbeat.com reports. The firm issued a buy rating and a $90.00 target price on the medical research company’s stock. Several other analysts also recently commented on EXAS. The Goldman Sachs Group decreased their price objective on […]
Guggenheim initiated coverage on shares of Exact Sciences (NASDAQ:EXAS – Free Report) in a research note released on Thursday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $90.00 target price on the medical research company’s stock. EXAS has been the subject of several other reports. Wolfe Research began coverage on shares of […]